| 期 |
栏目 |
标题 |
文件 |
| 卷 85, 编号 2 (2013) |
Editorial |
Difficulties and errors in the management tactics of patients with chronic pancreatitis |
|
| 卷 86, 编号 2 (2014) |
Editorial |
Evolution of clinical ideas about Zollinger-Ellison syndrome |
|
| 卷 86, 编号 3 (2014) |
Editorial |
Eradication therapy for Helicobacter pylori infection: Review of world trends |
|
| 卷 86, 编号 8 (2014) |
Editorial |
New approaches to diagnosing and treating Crohn's disease |
|
| 卷 86, 编号 4 (2014) |
Editorial |
Alcoholic liver disease: State-of-the-art |
|
| 卷 86, 编号 8 (2014) |
Editorial |
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases |
|
| 卷 87, 编号 4 (2015) |
Editorial |
Evolution of ideas on microscopic colitis |
|
| 卷 87, 编号 8 (2015) |
Editorial |
Helicobacter pylori infection and extragastroduodenal diseases |
|
| 卷 88, 编号 2 (2016) |
Editorial |
Nutritional status in patients with chronic pancreatitis |
(Rus)
|
| 卷 88, 编号 4 (2016) |
Editorial |
The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C |
(Rus)
|
| 卷 89, 编号 2 (2017) |
Editorial |
Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease |
(Rus)
|
| 卷 89, 编号 2 (2017) |
Editorial |
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice |
(Rus)
|
| 卷 89, 编号 8 (2017) |
Editorial |
Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
High resolution manometry and new classification of esophageal motility disorders |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program “odyssey” |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
Features of the functional activity of macrophage link of immunity with gastroesophageal reflux disease depending on the type of reluctate: in vitro model |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
The cardiovascular system in patients with functional and inflammatory bowel diseases |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications |
(Rus)
|
| 卷 92, 编号 1 (2020) |
Editorial |
The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study |
(Rus)
|
